Serum Metabolomic Response to Long-Term Supplementation with all-rac-α-Tocopheryl Acetate in a Randomized Controlled Trial
Background. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study, a randomized controlled cancer prevention trial, showed a 32% reduction in prostate cancer incidence in response to vitamin E supplementation. Two other trials were not confirmatory, however. Objective. We compared the c...
Saved in:
| Main Authors: | Alison M. Mondul, Steven C. Moore, Stephanie J. Weinstein, Anne M. Evans, Edward D. Karoly, Satu Männistö, Joshua N. Sampson, Demetrius Albanes |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Journal of Nutrition and Metabolism |
| Online Access: | http://dx.doi.org/10.1155/2016/6158436 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer.
by: Gabriella M Anic, et al.
Published: (2014-01-01) -
Circulating thyroxine, thyroid-stimulating hormone, and hypothyroid status and the risk of prostate cancer.
by: Alison M Mondul, et al.
Published: (2012-01-01) -
Mitigation of radiation mediated testicular dysfunction by α-tocopheryl succinate: PPAR-γ related pathway
by: Heba A. Gheita, et al.
Published: (2025-06-01) -
Assessment of Alpha-Tocopheryl Acetate and Metformin Hydrochloride as Independent Agents on Human Dermal Fibroblast Viability: Findings from MTT Assay
by: Nayla Majeda Alfarafisa, et al.
Published: (2025-06-01) -
rac-2-{3-[1-(Acetyloxy)ethyl]-2,2-dimethylcyclobutyl}acetic acid
by: Dieter Schollmeyer, et al.
Published: (2024-12-01)